1. Home
  2. XELB vs CANF Comparison

XELB vs CANF Comparison

Compare XELB & CANF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Xcel Brands Inc.

XELB

Xcel Brands Inc.

BUY

Current Price

$0.36

Market Cap

8.4M

Sector

Miscellaneous

ML Signal

BUY

Logo Can-Fite Biopharma Ltd Sponsored ADR (Israel)

CANF

Can-Fite Biopharma Ltd Sponsored ADR (Israel)

N/A

Current Price

$1.78

Market Cap

6.7M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
XELB
CANF
Founded
2011
1994
Country
United States
Israel
Employees
N/A
N/A
Industry
Multi-Sector Companies
Biotechnology: Pharmaceutical Preparations
Sector
Miscellaneous
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.4M
6.7M
IPO Year
2011
2011

Fundamental Metrics

Financial Performance
Metric
XELB
CANF
Price
$0.36
$1.78
Analyst Decision
Buy
Buy
Analyst Count
2
2
Target Price
$4.00
★ $7.50
AVG Volume (30 Days)
★ 1.4M
24.4K
Earning Date
11-18-2026
09-08-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 48.37
N/A
EPS
N/A
★ N/A
Revenue
N/A
N/A
Revenue This Year
$30.13
N/A
Revenue Next Year
$99.55
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.27
$0.17
52 Week High
$2.47
$10.40

Technical Indicators

Market Signals
Indicator
XELB
CANF
Relative Strength Index (RSI) 26.27 28.80
Support Level $0.27 $1.75
Resistance Level $1.16 $2.27
Average True Range (ATR) 0.09 0.09
MACD -0.00 0.01
Stochastic Oscillator 15.71 11.79

Price Performance

Historical Comparison
XELB
CANF

About XELB Xcel Brands Inc.

Xcel Brands Inc is a media and brand management company. It is engaged in design, merchandising and planning, sourcing and production, licensing, marketing, and brand development. The company offers branded apparel, footwear, accessories, jewelry, home goods, and other consumer products. Its brand portfolio consists of the Isaac Mizrahi, Judith Ripka, H Halston, C Wonder, and the Highline Collective brands. The company licenses its brands to third parties, provides certain designs, production, and marketing services, and generates licensing, design, and service fee revenues through contractual arrangements and other agreements.

About CANF Can-Fite Biopharma Ltd Sponsored ADR (Israel)

Can Fite Biopharma Ltd is a clinical-stage biopharmaceutical company. The company focuses on developing orally bioavailable small-molecule drugs targeting the A3 adenosine receptor for treating cancer, inflammatory diseases, liver disorders, and related conditions. It has a pipeline of proprietary drug candidates in Phase II and Phase III clinical development. The company's platform targets the A3 adenosine receptor (A3AR), which is more expressed in inflammatory and cancerous cells than in normal cells. Its pipeline drugs include Namodenoson, Piclidenoson, CF602, and Cannabinoids.

Share on Social Networks: